← Back
$PHAT All transactions

Phathom Pharmaceuticals, Inc.

F

$ Value

$564K

Shares

48,375

Price

$12

Filed

Sep 26

Insider

Name

Basta Steven L

Title

President and CEO

CIK

0001417397

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-25

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

41,625

Footnotes

Represents shares underlying the performance stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation. | Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer. | On April 3, 2025, the reporting person was granted 360,000 performance stock units, of which 90,000 vested on September 25, 2025 due to the achievement of the applicable stock price hurdle. The remaining performance stock units will vest based on the achievement of stock price hurdles over a period of four years following the grant date, subject to the reporting person's continued service through the date each such stock price hurdle is achieved.

Filing Info

Accession No.

0001193125-25-220950

Form Type

4

Issuer CIK

0001783183

Basta Steven L's History

Date Ticker Type Value
2026-02-10 PHAT A $0
2026-02-10 PHAT F $80K
2026-01-02 PHAT A $0
2026-01-02 PHAT A $0
2025-12-17 PHAT A $0
2025-12-17 PHAT F $484K
2025-12-12 VYNE A $0
2025-11-28 PHAT M $0
2025-11-28 PHAT F $756K
2025-11-28 PHAT M $0

Other Insiders at PHAT (90d)

Insider Bought Sold Last
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
2026-02-10
Basta Steven L
President and CEO
2026-02-10
Parikh Asit 2026-03-10
Breedlove Robert Charles
Principal Accounting Officer
2026-02-27